Active Ingredients: Ciprofloxacin
J Clin Microbiol.They rank fourth as causes of intensive care unit ICU acquired pneumonia, fifth as causes of ICU acquired bacteremia and sixth as causes of ICU acquired urinary tract infection 225. The classic clinical presentation is dramatic: toxic presentation with sudden onset of high fever and hemoptysis currant jelly sputum.
Nikaido H. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother.
Nomura K, Yoshida T. Antimicrob Agents Chemother. J Clin Microbiol. Hospital-acquired infections due to gram-negative bacteria. N Engl J Med.
Infect Control Hosp Epidemiol. Antimicrob Agents Chemother. Antimicrob Agents Chemother. Diagn Microbiol Infect Dis. Ann Intern Med.
J Infect Dev Ctries. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: results from SMART Study for Monitoring Antimicrobial Resistance Trends.
J Antimicrobe Chemother. Microb Drug Resist;9:257-264. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals .
Diagn Microbiol Infect Dis;78: 443-448. Serratia infections in a general hospital: characteristics and outcomes.
Beta-Lactam resistance in Gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 19 -839. Inducible b-lactamases: clinical and epidemiologic implications for use of newer cephalosporins.
Rev Infect Dis 19 -838. Open Microbiol J.
Phenotypic detection of extended-spectrum and AmpC beta-lactamases by a new spot-inoculation method and modified three-dimensional extract test: comparison with the conventional three-dimensional extract test.
J Antimicrob Chemother. J Bacteriol.
Antimicrob Agents Chemother.